Dasatinib inhibits c-src phosphorylation and prevents the proliferation of Triple-Negative Breast Cancer (TNBC) cells which overexpress Syndecan-Binding Protein (SDCBP)-Reference-Cited by-同舟云学术

Dasatinib inhibits c-src phosphorylation and prevents the proliferation of Triple-Negative Breast Cancer (TNBC) cells which overexpress Syndecan-Binding Protein (SDCBP)

Published:2017-01-31 Issue:1 Volume:12 Page:e0171169
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Qian Xiao-Long,Zhang Jun,Li Pei-Ze,Lang Rong-Gang,Li Wei-Dong,Sun Hui,Liu Fang-Fang,Guo Xiao-Jing,Gu Feng,Fu Li

Funder

National Natural Science Foundation of China

National Natural Science Foundation of Tianjin City, China

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference50 articles.

1. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications;T Sorlie;Proc Natl Acad Sci USA,2001

2. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease;G Bianchini;Nat Rev Clin Oncol,2016

3. Descriptive analysis of estrogen receptor (ER) negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype—A population-based study from the California Cancer Registry;KR Bauer;Cancer,2007

4. Triple-negative breast cancer: clinical features and patterns of recurrence;R Dent;Clin Cancer Res,2007

5. New treatment strategies for patients with triple-negative breast cancer;C Liedtke;Curr Opin Obstet Gynecol,2015

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small Molecule Therapeutics in the Pipeline Targeting for Triple-Negative Breast Cancer: Origin, Challenges, Opportunities, and Mechanisms of Action;International Journal of Molecular Sciences;2024-06-06

2. Recent updates on c-Src kinase and Src-Abl nonreceptor tyrosine kinases inhibitors;Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy;2024

3. In Vitro and In Vivo Effects of Docetaxel and Dasatinib in Triple-Negative Breast Cancer: A Research Study;Cureus;2023-08-15

4. Molecular structure and bioactivities of 2, 4-Ditert butyl phenol extracted from Plumbago zeylanica, investigated using HPLC and NMR;Biomass Conversion and Biorefinery;2023-07-18

5. Simultaneous determination of paclitaxel and dasatinib in rat plasma and pharmacokinetic study on liquid chromatography‐tandem mass spectrometry;SEPARATION SCIENCE PLUS;2023-06-13